Dr Contag founded Cobalt Technologies in 2006 and served as CEO. Prior to starting Cobalt, Dr Contag founded Xenogen, a biotechnology company.
Dr Contag received her PhD in microbiology from the University of Minnesota Medical School and completed her postdoctoral training at Stanford University School of Medicine.
Richard Taney, president and CEO of Delcath, said: “Dr Contag’s biotech, pharmaceutical and testing experience will be particularly relevant as we prepare for meetings with the FDA regarding regulatory approvals and ultimately, commercialization. Her extensive industry relationships will provide opportunities to expand the recognition and value of the Delcath technology.”